Does Aetna Cover Weight Loss Treatment in Florida? A 2026 Guide

Last updated: September 2, 2026

Aetna commercial plans in Florida may cover medically necessary obesity evaluation, follow-up, and some weight-loss medications when the visit is in network and allowed on your medical policy and CVS/Caremark list. Coverage is not automatic. Federal MHPAEA and Fla. Stat. § 627.668 set a floor for many fully insured mental-health benefits. They do not force every GLP-1, phentermine, Contrave, or orlistat product onto a preferred tier. Always verify your own benefits before you book.

See if you may qualify for online weight care through Klarity’s network of 2,000+ licensed providers. You can also browse conditions we treat.

TLDR

• Aetna may cover medically necessary weight-management visits and some anti-obesity drugs in Florida. Benefits vary by employer PPO/HMO, Florida Marketplace, Medicare Advantage, and Medicaid managed care products.
• Federal MHPAEA plus Fla. Stat. § 627.668 (optional/make-available mental health coverage on many fully insured policies) apply to many commercial products. They do not rewrite self-funded ERISA plan documents or Medicare Advantage formularies. § 627.668 is a mental-health make-available rule, not a GLP-1 mandate.
• Florida Statutes § 456.47 governs telehealth practice. It does not force Aetna to pay every video visit. Coverage still depends on the plan.
• Pharmacy benefits typically run through CVS/Caremark. On many Caremark lists, Zepbound was removed July 1, 2025 and is scheduled for reinstatement October 1, 2026. Wegovy, Saxenda, Contrave, orlistat, and phentermine still follow their own PA, step, and BMI rules. Reinstatement does not guarantee payment for your NDC.
• Cigna PA Policy IP0477 (effective May 15, 2026 on many Cigna commercial lists) typically requires prior authorization for stimulants. It is a Cigna/ESI ADHD policy. Do not treat it as an Aetna GLP-1 PA rule.
• Phentermine and Qsymia are Schedule IV. GLP-1s (Wegovy, Zepbound, Saxenda), Contrave, and orlistat are typically unscheduled. HHS/DEA telemedicine flexibilities for prescribing many controlled medications currently run through December 31, 2026.
• Cigna/ESI did not remove Zepbound the same way Caremark did. Do not copy Cigna Florida obesity answers onto an Aetna card.
• Medicare GLP-1 Bridge ($50/month Wegovy/Zepbound/Foundayo via CMS, starting July 1, 2026) is a Medicare obesity program. It does not pay for commercial Aetna GLP-1s.
• Verify benefits on Aetna member tools and Caremark. For many fully insured Florida complaints, Florida DFS Division of Consumer Services / FLOIR consumer help is often 1-877-693-5236 (1-877-MY-FL-CFO). Medicare Advantage appeals follow CMS, then often Maximus IRE at 1-855-887-6668. AHCA/Medicaid products follow Florida Medicaid rules, not this commercial page. If you are in crisis, call or text 988.

Disclaimer: This article is educational. It is not a benefits determination, diagnosis, or guarantee of payment. Coverage varies by plan. Verify benefits with Aetna and your clinician before you book.

Does Aetna cover weight loss treatment in Florida?

Often, some of it, with caveats. Evaluation visits and medication management may process as medical benefits on many Aetna commercial plans when the visit is medically necessary and in network. Medication is a separate pharmacy question. Copays, deductibles, BMI criteria, step therapy, and whether Klarity is in network still sit in your Summary of Benefits and Coverage, medical policy, and Caremark drug list.

Self-funded ERISA employer plans follow federal rules and the plan document more than Fla. Stat. § 627.668. Medicare Advantage, Medicaid, and dual-eligible products follow CMS and Florida Medicaid rules, not § 627.668 in the same way. Always treat this page as education, not a coverage determination.

Do not mix Aetna with Florida Blue (Blue Cross and Blue Shield of Florida), Anthem, or Cigna. Related Florida guides: Aetna Florida ADHD, Aetna Florida anxiety, Aetna Florida depression, and Cigna Florida weight loss.

Check if your plan may cover a weight-loss visit.

How common is adult obesity?

According to NCHS Data Brief No. 508, the prevalence of obesity among U.S. adults was 40.3% during August 2021–August 2023, with no significant differences between men and women. Severe obesity prevalence was 9.4% and was higher in women than men for each age group. From 2013-2014 through August 2021–August 2023, age-adjusted obesity did not change significantly, while severe obesity increased from 7.7% to 9.7%.

Those figures describe national epidemiology. They do not decide whether your Aetna Florida plan pays for a video visit or a brand-name GLP-1.

Parity in Florida: what § 627.668 does and does not do

Two layers matter in 2026:

1. Federal MHPAEA. Group health plans and many individual plans that cover mental health generally cannot apply more restrictive financial requirements or treatment limitations than they apply to medical/surgical care in the same classification. Obesity pharmacotherapy is usually a medical or pharmacy benefit, not a mental-health benefit, so MHPAEA does not by itself force GLP-1 coverage.
2. Fla. Stat. § 627.668 addresses optional/make-available coverage for mental and nervous disorders on many fully insured policies written in Florida. See the statute text on Online Sunshine. It is a make-available mental health rule, not a mandate that Wegovy, Zepbound, phentermine, Contrave, or orlistat appear on every Aetna Florida formulary.

Self-funded ERISA plans, Medicare Advantage, and Medicaid products sit outside that fully insured commercial story. Do not quote § 627.668 as a reason Aetna “must” pay for a GLP-1.

Telehealth: Florida § 456.47 vs. Aetna payment

Florida Statutes § 456.47 sets practice standards for telehealth providers. A licensed clinician may evaluate and treat a Florida patient by telehealth when the visit meets the professional standard of care. That statute does not rewrite Aetna medical policy, Caremark PA, or network contracts. Aetna can still require in-network status, medical necessity, BMI documentation, and a covered place of service.

HHS/DEA telemedicine flexibilities for prescribing many controlled medications currently run through December 31, 2026. Phentermine and Qsymia (Schedule IV) can fall under those rules. GLP-1s, Contrave, and orlistat are typically unscheduled, so DEA scheduling is usually inapplicable to those products.

CVS/Caremark, Zepbound timing, and what Aetna actually decides

Most Aetna commercial pharmacy benefits run through CVS/Caremark. On many Caremark lists:

• Zepbound was removed July 1, 2025.
• Reinstatement is scheduled for October 1, 2026 on many lists, still with PA, step therapy, and BMI criteria.

Wegovy, Saxenda, Contrave, orlistat, and phentermine follow separate medical policies. A reinstatement date is not a payment guarantee. Your NDC, dose, and diagnosis codes still have to match the current list.

Cigna/ESI did not remove Zepbound the same way. Cigna PA Policy IP0477 is a stimulant/ADHD PA rule, not an Aetna obesity rule. If a friend has Cigna Florida coverage, use the Cigna Florida weight-loss guide instead of this page.

Medicare GLP-1 Bridge vs. commercial Aetna

Starting July 1, 2026, CMS’s Medicare GLP-1 Bridge may offer certain Medicare enrollees Wegovy, Zepbound, or Foundayo at $50/month under program rules. That is a Medicare obesity pathway. It does not pay commercial Aetna GLP-1 claims. Humana Medicare Advantage pages discuss that Bridge because Humana’s Florida commercial book is limited. This Aetna commercial page does not lead with it.

AHCA/Medicaid and dual-eligible products follow Florida Medicaid rules. Do not assume this commercial guide applies to those cards.

How to verify benefits and appeal

Call the number on your Aetna ID card. Ask about medical necessity for obesity evaluation, in-network telehealth, Caremark PA for the specific drug, BMI and comorbidity criteria, and Klarity’s network status. Keep the reference number.

For many fully insured Florida complaints, Florida DFS Division of Consumer Services can help at 1-877-693-5236. See DFS Consumer Services contact and FLOIR consumers. Medicare Advantage appeals follow CMS, then often Maximus IRE at 1-855-887-6668. Medicaid follows AHCA, not DFS in the same way.

If you are in crisis, call or text 988.

See if you may qualify for online weight care. You can also browse conditions we treat.

FAQ

Does Aetna cover Wegovy or Zepbound in Florida?

Sometimes, when the drug is on your Caremark list, PA is approved, and medical necessity is documented. Zepbound timing on many Caremark lists is July 1, 2025 removal and October 1, 2026 reinstatement. That still is not a guarantee for your NDC.

Does Florida law force Aetna to cover GLP-1s?

No. Fla. Stat. § 627.668 is a mental-health make-available rule. It does not mandate obesity drugs. MHPAEA also does not, by itself, force GLP-1 coverage.

Can I get an online weight-loss visit on Aetna in Florida?

Many plans may pay medically necessary telehealth when the clinician and place of service are in network. § 456.47 governs practice, not payment. Verify before you book.

Is this the same as Florida Blue, Anthem, or Cigna?

No. Florida Blue, Anthem, Cigna/ESI, and Aetna/Caremark use different networks and lists. Use the matching 2026 guide for your card.

Disclaimer: Coverage varies by plan. This page is not a determination of benefits. Verify with Aetna and your clinician. If you are in crisis, call or text 988.